Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depression

Neuropharmacology

Volumn 91, Issue , 2015, Pages 97-102

  Landau, Anne M ^a,b   Phan, Jenny Ann ^a,b   Iversen, Peter ^a   Lillethorup, Thea P ^a,b   Simonsen, Mette ^a   Wegener, Gregers ^b,c   Jakobsen, Steen ^a   Doudet, Doris J ^a,d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c NORTH WEST UNIVERSITY   (South Africa)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Depression; Flinders sensitive line; Noradrenaline; Positron emission tomography; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; NORADRENALIN; CARBON; YOHIMBINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; FEMALE; IN VIVO STUDY; NONHUMAN; NORADRENERGIC SYSTEM; PONS; PROTEIN FUNCTION; RAT; RECEPTOR BINDING; THALAMUS; ANIMAL; BRAIN; DIAGNOSTIC USE; DISEASE MODEL; METABOLISM; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FEMALE; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; YOHIMBINE;

EID: 84920749697     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.12.025     Document Type: Article

References (43)

1. A.K. Alstrup, A.M. Landau, J.E. Holden, S. Jakobsen, A.C. Schacht, H. Audrain, G. Wegener, A.K. Hansen, A. Gjedde, and D.J. Doudet Effects of anesthesia and species on the uptake or binding of radioligands in vivo in the Gottingen minipig Biomed. Res. Int. 2013 2013 808713
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV 2013 American Psychiatric Association Washington DC
3. D.S. Baldwin Serotonin noradrenaline reuptake inhibitors: a new generation of treatment for anxiety disorders Int. J. Psychiatry Clin. Pract. 10 Suppl. 2 2006 12 15
4. I. Biaggioni, R.M. Robertson, and D. Robertson Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure J. Clin. Pharmacol. 34 1994 418 423
5. N. Brunello, P. Blier, L.L. Judd, J. Mendlewicz, C.J. Nelson, D. Souery, J. Zohar, and G. Racagni Noradrenaline in mood and anxiety disorders: basic and clinical studies Int. Clin. Psychopharmacol. 18 2003 191 202
6. D.S. Charney, G.R. Heninger, and A. Breier Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder Arch. Gen. Psychiatry 41 1984 751 763
7. F. Chen, T.M. Madsen, G. Wegener, and J.R. Nyengaard Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression Hippocampus 20 2010 1376 1384
8. R.M. Cohen, I.C. Campbell, M.R. Cohen, T. Torda, D. Pickar, L.J. Siever, and D.L. Murphy Presynaptic noradrenergic regulation during depression and antidepressant drug treatment Psychiatry Res. 3 1980 93 105
9. C. Cottingham, and Q. Wang alpha2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy Neurosci. Biobehav. Rev. 36 2012 2214 2225
10. P.V. Escriba, A. Ozaita, and J.A. Garcia-Sevilla Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims Neuropsychopharmacology 29 2004 1512 1521
11. M.S. Gandelman, R.M. Baldwin, S.S. Zoghbi, Y. Zea-Ponce, and R.B. Innis Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil J. Pharm. Sci. 83 1994 1014 1019
12. A.M. Gonzalez, J. Pascual, J.J. Meana, F. Barturen, C. del Arco, A. Pazos, and J.A. Garcia-Sevilla Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims J. Neurochem. 63 1994 256 265
13. J. Gonzalez-Maeso, R. Rodriguez-Puertas, J.J. Meana, J.A. Garcia-Sevilla, and J. Guimon Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors Mol. Psychiatry 7 2002 755 767
14. S. Hasegawa, K. Nishi, A. Watanabe, D.H. Overstreet, and M. Diksic Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study Neurochem. Int. 48 2006 358 366
15. S. Jakobsen, K. Pedersen, D.F. Smith, S.B. Jensen, O.L. Munk, and P. Cumming Detection of alpha2-adrenergic receptors in brain of living pig with 11C-yohimbine J. Nucl. Med. 47 2006 2008 2015
16. P.A. Jimenez-Vasquez, Z. Diaz-Cabiale, L. Caberlotto, I. Bellido, D. Overstreet, K. Fuxe, and A.A. Mathe Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression Eur. Neuropsychopharmacol. 17 2007 298 308
17. R.C. Kessler The effects of stressful life events on depression Annu. Rev. Psychol. 48 1997 191 214
18. T. Klengel, and E.B. Binder Gene-environment interactions in major depressive disorder Can. J. Psychiatry 58 2013 76 83
19. O. Kotsovolou, M. Ingelman-Sundberg, M.A. Lang, M. Marselos, D.H. Overstreet, Z. Papadopoulou-Daifoti, I. Johanson, A. Fotopoulos, and M. Konstandi Hepatic drug metabolizing profile of Flinders Sensitive Line rat model of depression Prog. Neuropsychopharmacol. Biol. Psychiatry 34 2010 1075 1084
20. A.M. Landau, D.J. Doudet, and S. Jakobsen Amphetamine challenge decreases yohimbine binding to alpha2 adrenoceptors in Landrace pig brain Psychopharmacol. Berl. 222 2012 155 163
21. A.M. Landau, S. Dyve, S. Jakobsen, A.K. Alstrup, D. Doudet, and A. Gjedde Update: inhibition plots of [C-11]yohimbine binding yield consistent estimates of non-displaceable volumes of distribution in multiple tests J. Cereb. Blood Flow Metab. 32 2012 S36 S37
22. M. Laruelle Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review J. Cereb. Blood Flow. Metab. 20 2000 423 451
23. J. Logan, J.S. Fowler, N.D. Volkow, A.P. Wolf, S.L. Dewey, D.J. Schlyer, R.R. MacGregor, R. Hitzemann, B. Bendriem, and S.J. Gatley Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects J. Cereb. Blood Flow. Metab. 10 1990 740 747
24. H.K. Manji, W.C. Drevets, and D.S. Charney The cellular neurobiology of depression Nat. Med. 7 2001 541 547
25. M. Marcus, M.T. Yasamy, M. Van Ommeren, D. Chisholm, and S. Saxena Depression, a Global Public Health Concern 2012 WHO Department of Mental Health and Substance Abuse
26. D.M. Marks, C.U. Pae, and A.A. Patkar Triple reuptake inhibitors: the next generation of antidepressants Curr. Neuropharmacol. 6 2008 338 343
27. G.A. Ordway, J. Schenk, C.A. Stockmeier, W. May, and V. Klimek Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression Biol. Psychiatry 53 2003 315 323
28. D.H. Overstreet Selective breeding for increased cholinergic function: development of a new animal model of depression Biol. Psychiatry 21 1986 49 58
29. D.H. Overstreet, E. Friedman, A.A. Mathe, and G. Yadid The Flinders Sensitive Line rat: a selectively bred putative animal model of depression Neurosci. Biobehav. Rev. 29 2005 739 759
30. D.H. Overstreet, A. Keeney, and S. Hogg Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression Eur. J. Pharmacol. 492 2004 195 201
31. D.H. Overstreet, and R.W. Russell Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists Psychopharmacol. Berl. 78 1982 150 155
32. D.H. Overstreet, and G. Wegener The flinders sensitive line rat model of depression-25 years and still producing Pharmacol. Rev. 65 2013 143 155
33. H.L. Pearce, A.R. Safa, N.J. Bach, M.A. Winter, M.C. Cirtain, and W.T. Beck Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance Proc. Natl. Acad. Sci. U. S. A. 86 1989 5128 5132
34. 11C]yohimbine binding to α2 adrenoceptors in rat brain in vivo J. Cereb. Blood Flow. Metab. 2014 10.1038/jcbfm.2014.225 (in press)
35. K.J. Ressler, and C.B. Nemeroff Role of norepinephrine in the pathophysiology and treatment of mood disorders Biol. Psychiatry 46 1999 1219 1233
36. I. Roth-Deri, A. Friedman, L. Abraham, E. Lax, Y. Flaumenhaft, Y. Dikshtein, and G. Yadid Antidepressant treatment facilitates dopamine release and drug seeking behavior in a genetic animal model of depression Eur. J. Neurosci. 30 2009 485 492
37. D.J. Rubins, W.P. Melega, G. Lacan, B. Way, A. Plenevaux, A. Luxen, and S.R. Cherry Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain Neuroimage 20 2003 2100 2118
38. J.J. Schildkraut The catecholamine hypothesis of affective disorders: a review of supporting evidence Am. J. Psychiatry 122 1965 509 522
39. K. Schwartz, G. Yadid, A. Weizman, and M. Rehavi Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression Brain Res. 965 2003 174 179
40. S.W. Tam, M. Worcel, and M. Wyllie Yohimbine: a clinical review Pharmacol. Ther. 91 2001 215 243
41. M.L. Wong, M.A. Kling, P.J. Munson, S. Listwak, J. Licinio, P. Prolo, B. Karp, I.E. McCutcheon, T.D. Geracioti Jr., M.D. DeBellis, K.C. Rice, D.S. Goldstein, J.D. Veldhuis, G.P. Chrousos, E.H. Oldfield, S.M. McCann, and P.W. Gold Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone Proc. Natl. Acad. Sci. U. S. A. 97 2000 325 330
42. A. Zangen, D.H. Overstreet, and G. Yadid Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment Brain Res. 824 1999 243 250
43. J.K. Zolnerciks, C.L. Booth-Genthe, A. Gupta, J. Harris, and J.D. Unadkat Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions J. Pharm. Sci. 100 2011 3055 3061